Suriname Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Suriname Healthcare Press.

Press releases published on October 9, 2026

2 hours ago

How to Tell Whether an E-commerce Brand Has Outgrown Its In-House Customer Support

Indeterminate GlobeNewswire

3 hours ago

EliseAI Named as Co-Development Partner with Nextech to Bring Agentic VoiceAI to Specialty Practices

Indeterminate GlobeNewswire

4 hours ago

Global Peripheral Blood Mononuclear Cells (PBMCs) Market to Reach $577.2 Million by 2031

Indeterminate GlobeNewswire

4 hours ago

SkinHealth Systems Announces Reverse Stock Split

Indeterminate GlobeNewswire

4 hours ago

HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors

Indeterminate GlobeNewswire

4 hours ago

Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026

Indeterminate GlobeNewswire

4 hours ago

Herbal teas for unwinding after a stressful day: a guide to the evening wind-down ritual, relaxation before bed and a restful night’s sleep

Indeterminate GlobeNewswire

4 hours ago

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

Indeterminate GlobeNewswire

5 hours ago

New Study Shows Cortical Disarray Measurement (CDM®) Can Reflect Microscopic Patterns of Pathology in Frontotemporal Dementia

Indeterminate GlobeNewswire

5 hours ago

Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical

Indeterminate GlobeNewswire

5 hours ago

Nuvectis Pharma to Participate in the Maxim Growth Summit 2026

Indeterminate GlobeNewswire

5 hours ago

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

Indeterminate GlobeNewswire

5 hours ago

Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

Indeterminate GlobeNewswire

5 hours ago

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

Indeterminate GlobeNewswire

5 hours ago

Nextech Unveils Agentic AI Capabilities for Patient Experience through Partnerships with Assort Health and EliseAI

Indeterminate GlobeNewswire

5 hours ago

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease

Indeterminate GlobeNewswire

5 hours ago

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

Indeterminate GlobeNewswire

5 hours ago

Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe

Indeterminate GlobeNewswire

6 hours ago

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference 

Indeterminate GlobeNewswire

6 hours ago

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia

Indeterminate GlobeNewswire